Challa, T.R. (2026) “A 3% topical gel formulation of tenofovir disoproxil fumarate (TDF) for the treatment of human immunodeficiency virus (HIV) by experimental approach”, Current Issues in Pharmacy and Medical Sciences, 39(1), pp. 7–13. doi:10.12923/cipms-2026-0002.